Capital World Investors
Source: SEC Form 13F · as of Mar 2026Capital World Investors holds 21 biotech & pharma companies tracked by BioSniper, totaling $17.08B in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$17.08B
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 41,283,933 | $5.75B |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10,802,348 | $3.57B |
| ARGXARGENX SE | 2,256,216 | $1.65B |
| IONSIONIS PHARMACEUTICALS INC | 21,186,369 | $1.59B |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,419,000 | $1.10B |
| MRNAModerna, Inc. | 18,697,694 | $949.8M |
| JAZZJazz Pharmaceuticals plc | 2,673,376 | $505.4M |
| ONCBeOne Medicines Ltd. | 1,622,687 | $481.9M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 11,109,034 | $355.6M |
| TEVATeva Pharmaceutical Industries Limited | 8,833,566 | $266.1M |
| INSMINSMED Inc | 1,362,291 | $222.7M |
| CNTACentessa Pharmaceuticals plc | 4,832,548 | $191.9M |
| GRFSGrifols S.A. | 22,924,990 | $183.9M |
| KALVKalVista Pharmaceuticals, Inc. | 2,808,583 | $56.5M |
| SRRKScholar Rock Holding Corp | 1,128,752 | $55.5M |
| ABCLAbCellera Biologics Inc. | 13,361,096 | $46.6M |
| SYRESpyre Therapeutics, Inc. | 666,564 | $33.6M |
| APGEApogee Therapeutics, Inc. | 348,674 | $29.3M |
| CYTKCYTOKINETICS INC | 242,041 | $16.0M |
| NRIXNurix Therapeutics, Inc. | 893,327 | $13.8M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 115,693 | $10.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.